Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Akebia Therapeutics (AKBA) Long-Term Debt Issuances (2024 - 2025)

Historic Long-Term Debt Issuances for Akebia Therapeutics (AKBA) over the last 2 years, with Q1 2025 value amounting to $10.0 million.

  • Akebia Therapeutics' Long-Term Debt Issuances fell 7297.3% to $10.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year decrease of 7777.78%. This contributed to the annual value of $45.0 million for FY2024, which is N/A changed from last year.
  • Per Akebia Therapeutics' latest filing, its Long-Term Debt Issuances stood at $10.0 million for Q1 2025, which was down 7297.3% from $8.0 million recorded in Q2 2024.
  • In the past 5 years, Akebia Therapeutics' Long-Term Debt Issuances ranged from a high of $37.0 million in Q1 2024 and a low of $8.0 million during Q2 2024